Financial statements Mito-Pharma Alpha
Balance sheet of Mito-Pharma Alpha
Company age:
Age:
8 y. 5 m. 4 d.
Share capital:
Share capital:
50 000 PLN
Balance sheet data of MITO-PHARMA ALPHA
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 93 467,05 | 325 647,02 | 261 744,30 | 172 074,26 | 162 932,25 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 1 140,00 | 1 080,00 |
| B. Current assets | 93 467,05 | 325 647,02 | 261 744,30 | 170 934,26 | 161 852,25 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 93 467,05 | 325 647,02 | 261 744,30 | 172 074,26 | 162 932,25 |
| A. Equity | 11 797,55 | 6 076,19 | 746,27 | -2 835,36 | 26 203,83 |
| B. Liabilities and provisions for liabilities | 81 669,50 | 319 570,83 | 260 998,03 | 174 909,62 | 136 728,42 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 81 669,50 | 319 570,83 | 260 998,03 | 174 909,62 | 136 728,42 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.